ALX Oncology Holdings Inc. (ALXO) Tops Q4 EPS by 12c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral